The SITS-MOST registry

Neurological Sciences

Volumn 27, Issue SUPPL. 3, 2006, Pages

  Toni, Danilo ^a   Lorenzano, S ^a   Puca, E ^a   Prencipe, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Acute ischaemic stroke; Intravenous thrombolysis

Indexed keywords

ALTEPLASE;

BRAIN HEMORRHAGE; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DRUG APPROVAL; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; EUROPE; EXPERIMENTAL STUDY; FIBRINOLYTIC THERAPY; FUNCTIONAL INDEPENDENCE MEASURE; HEALTH CARE ORGANIZATION; HUMAN; INTERNET; LICENCE; PATIENT MONITORING; RANDOMIZATION; REGISTER; REVIEW; STROKE; SYMPTOMATOLOGY; SYSTEMATIC REVIEW;

CEREBROVASCULAR ACCIDENT; DATABASES, FACTUAL; FIBRINOLYTIC AGENTS; HUMANS; RANDOMIZED CONTROLLED TRIALS; REGISTRIES; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 33744786292     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-006-0632-9     Document Type: Review

References (12)

1. Consensus Karolinska Stroke Update (2002) Thrombolysis for acute ischemic stroke. The 4th Karolinska Stroke Update meeting on November 12, 2002
2. The National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1587
3. Hacke W, Kaste M, Fieschi C et al (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 274:1017-1025
4. Hacke W, Kaste M, Fieschi C et al, for the Second European-Australasian Acute Stroke Study Investigators (1998) Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 352:1245-1251
5. Clark WM, Wissman S, Albers GW et al (1999) Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: A randomised controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 282:2019-2026
6. Mori E, Yoneda Y, Tabuchi M et al (1992) Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 42:976-982
7. Yamaguchi T, Japanese Thrombolysis Study Group (1993) Intravenous tissue plasminogen activator in acute carotid artery territory stroke: A placebo controlled, double blind trial. In: Del Zoppo GJ, Mori E, Hacke W (eds) Thrombolytic therapy in acute ischemic stroke II. Springer Verlag, New York, pp 59-65
8. Haley EC Jr, Brott TG, Sheppard GL et al (1993) Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. Stroke 24:1000-1004
9. Wardlaw JM, del Zoppo G, Yamaguchi T (1999) Thrombolysis for acute ischaemic stroke. (Cochrane Review) In: The Cochrane Library, Oxford: Update Software, Issue 4
10. Hacke W, Brott T, Caplan L et al (1999) Thrombolysis in acute ischemic stroke: Controlled trials and clinical experience. Neurology 53[7 Suppl 4]:3-14
11. Graham GD (2003) Tissue plasminogen activator for acute ischaemic stroke in clinical practice. A meta-analysis of safety data. Stroke 34:2847-2850
12. Safe Implementation of Thrombolysis in Stroke-Monitoring Study, SITS-MOST. www.acutestroke.org